These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37886563)

  • 21. Antitumor mechanism of kangliu pill on gliomas in mice through PI3K-Akt signaling pathway.
    Chen F; Cui JJ; Jiang DC; Wang HZ; Zhuang W; Feng YN; Lin XL; Xi SY
    J Ethnopharmacol; 2023 May; 307():116252. PubMed ID: 36775078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of Polygenic Score and the involvement of Cholinergic and Glutamatergic Pathways with Lithium Treatment Response in Patients with Bipolar Disorder.
    Amare A; Thalamuthu A; Schubert KO; Fullerton J; Ahmed M; Hartmann S; Papiol S; Heilbronner U; Degenhardt F; Tekola-Ayele F; Hou L; Hsu YH; Shekhtman T; Adli M; Akula N; Akiyama K; Ardau R; Arias B; Aubry JM; Backlund L; Bhattacharjee AK; Bellivier F; Benabarre A; Bengesser S; Biernacka J; Birner A; Marie-Claire C; Cervantes P; Chen HC; Chillotti C; Cichon S; Cruceanu C; Czerski P; Dalkner N; Del Zompo M; DePaulo JR; Etain B; Jamain S; Falkai P; Forstner AJ; Frisén L; Frye M; Gard S; Garnham J; Goes F; Grigoroiu-Serbanescu M; Fallgatter A; Stegmaier S; Ethofer T; Biere S; Petrova K; Schuster C; Adorjan K; Budde M; Heilbronner M; Kalman J; Oraki Kohshour M; Reich-Erkelenz D; Schaupp S; Schulte E; Senner F; Vogl T; Anghelescu IG; Arolt V; Dannlowski U; Dietrich DE; Figge C; Jäger M; Lang F; Juckel G; Spitzer C; Reimer J; Schmauß M; Schmitt A; Konrad C; von Hagen M; Wiltfang J; Zimmermann J; Andlauer T; Fischer A; Bermpohl F; Kraft V; Matura S; Gryaznova A; Falkenberg I; Yildiz C; Kircher T; Schmidt J; Koch M; Gade K; Trost S; Haußleiter I; Lambert M; Rohenkohl AC; Kraft V; Grof P; Hashimoto R; Hauser J; Herms S; Hoffmann P; Jiménez E; Kahn JP; Kassem L; Kuo PH; Kato T; Kelsoe J; Kittel-Schneider S; Ferensztajn-Rochowiak E; König B; Kusumi I; Laje G; Landén M; Lavebratt C; Leboyer M; Leckband SG; Tortorella A; Manchia M; Martinsson L; McCarthy M; McElroy SL; Colom F; Mitjans M; Mondimore F; Monteleone P; Nievergelt C; Nöthen M; Novak T; O'Donovan C; Ozaki N; Pfennig A; Pisanu C; Potash J; Reif A; Reininghaus E; Rouleau G; Rybakowski JK; Schalling M; Schofield P; Schweizer BW; Severino G; Shilling PD; Shimoda K; Simhandl C; Slaney C; Squassina A; Stamm T; Stopkova P; Maj M; Turecki G; Vieta E; Veeh J; Witt S; Wright A; Zandi P; Mitchell P; Bauer M; Alda M; Rietschel M; McMahon F; Schulze TG; Millischer V; Clark S; Baune B
    Res Sq; 2023 Feb; ():. PubMed ID: 36824922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Polygenic Score for Schizophrenia and HLA Antigen and Inflammation Genes With Response to Lithium in Bipolar Affective Disorder: A Genome-Wide Association Study.
    ; Amare AT; Schubert KO; Hou L; Clark SR; Papiol S; Heilbronner U; Degenhardt F; Tekola-Ayele F; Hsu YH; Shekhtman T; Adli M; Akula N; Akiyama K; Ardau R; Arias B; Aubry JM; Backlund L; Bhattacharjee AK; Bellivier F; Benabarre A; Bengesser S; Biernacka JM; Birner A; Brichant-Petitjean C; Cervantes P; Chen HC; Chillotti C; Cichon S; Cruceanu C; Czerski PM; Dalkner N; Dayer A; Del Zompo M; DePaulo JR; Étain B; Falkai P; Forstner AJ; Frisen L; Frye MA; Fullerton JM; Gard S; Garnham JS; Goes FS; Grigoroiu-Serbanescu M; Grof P; Hashimoto R; Hauser J; Herms S; Hoffmann P; Hofmann A; Jamain S; Jiménez E; Kahn JP; Kassem L; Kuo PH; Kato T; Kelsoe J; Kittel-Schneider S; Kliwicki S; König B; Kusumi I; Laje G; Landén M; Lavebratt C; Leboyer M; Leckband SG; Tortorella A; Manchia M; Martinsson L; McCarthy MJ; McElroy S; Colom F; Mitjans M; Mondimore FM; Monteleone P; Nievergelt CM; Nöthen MM; Novák T; O'Donovan C; Ozaki N; Ösby U; Pfennig A; Potash JB; Reif A; Reininghaus E; Rouleau GA; Rybakowski JK; Schalling M; Schofield PR; Schweizer BW; Severino G; Shilling PD; Shimoda K; Simhandl C; Slaney CM; Squassina A; Stamm T; Stopkova P; Maj M; Turecki G; Vieta E; Volkert J; Witt S; Wright A; Zandi PP; Mitchell PB; Bauer M; Alda M; Rietschel M; McMahon FJ; Schulze TG; Baune BT
    JAMA Psychiatry; 2018 Jan; 75(1):65-74. PubMed ID: 29121268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A genetic network model of cellular responses to lithium treatment and cocaine abuse in bipolar disorder.
    McEachin RC; Chen H; Sartor MA; Saccone SF; Keller BJ; Prossin AR; Cavalcoli JD; McInnis MG
    BMC Syst Biol; 2010 Nov; 4():158. PubMed ID: 21092101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of Attention-Deficit/Hyperactivity Disorder and Depression Polygenic Scores with Lithium Response: A Consortium for Lithium Genetics Study.
    Coombes BJ; Millischer V; Batzler A; Larrabee B; Hou L; Papiol S; Heilbronner U; Adli M; Akiyama K; Akula N; Amare AT; Ardau R; Arias B; Aubry JM; Backlund L; Bauer M; Baune BT; Bellivier F; Benabarre A; Bengesser S; Bhattacharjee AK; Cervantes P; Chen HC; Chillotti C; Cichon S; Clark SR; Colom F; Cruceanu C; Czerski PM; Dalkner N; Degenhardt F; Del Zompo M; DePaulo JR; Étain B; Falkai P; Ferensztajn-Rochowiak E; Forstner AJ; Frisen L; Gard S; Garnham JS; Goes FS; Grigoroiu-Serbanescu M; Grof P; Hashimoto R; Hauser J; Herms S; Hoffmann P; Jamain S; Jiménez E; Kahn JP; Kassem L; Kato T; Kelsoe JR; Kittel-Schneider S; König B; Kuo PH; Kusumi I; Laje G; Landén M; Lavebratt C; Leboyer M; Leckband SG; Maj M; Manchia M; Martinsson L; McCarthy MJ; McElroy SL; Mitchell PB; Mitjans M; Mondimore FM; Monteleone P; Nievergelt CM; Nöthen MM; Novák T; O'Donovan C; Osby U; Ozaki N; Pfennig A; Pisanu C; Potash JB; Reif A; Reininghaus E; Rietschel M; Rouleau GA; Rybakowski JK; Schalling M; Schofield PR; Schubert KO; Schweizer BW; Severino G; Shekhtman T; Shilling PD; Shimoda K; Simhandl C; Slaney CM; Squassina A; Stamm T; Stopkova P; Tortorella A; Turecki G; Vieta E; Witt SH; Zandi PP; Fullerton JM; Alda M; Frye MA; Schulze TG; McMahon FJ; Biernacka JM
    Complex Psychiatry; 2021 Dec; 7(3-4):80-89. PubMed ID: 36408127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Genetics of Response to and Side Effects of Lithium Treatment in Bipolar Disorder: Future Research Perspectives.
    Senner F; Kohshour MO; Abdalla S; Papiol S; Schulze TG
    Front Pharmacol; 2021; 12():638882. PubMed ID: 33867988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploring lithium's transcriptional mechanisms of action in bipolar disorder: a multi-step study.
    Akkouh IA; Skrede S; Holmgren A; Ersland KM; Hansson L; Bahrami S; Andreassen OA; Steen VM; Djurovic S; Hughes T
    Neuropsychopharmacology; 2020 May; 45(6):947-955. PubMed ID: 31652432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased AKT1/mTOR pathway mRNA expression in short-term bipolar disorder.
    Machado-Vieira R; Zanetti MV; Teixeira AL; Uno M; Valiengo LL; Soeiro-de-Souza MG; Oba-Shinjo SM; de Sousa RT; Zarate CA; Gattaz WF; Marie SK
    Eur Neuropsychopharmacol; 2015 Apr; 25(4):468-73. PubMed ID: 25726893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epistasis network centrality analysis yields pathway replication across two GWAS cohorts for bipolar disorder.
    Pandey A; Davis NA; White BC; Pajewski NM; Savitz J; Drevets WC; McKinney BA
    Transl Psychiatry; 2012 Aug; 2(8):e154. PubMed ID: 22892719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors associated with lithium efficacy in bipolar disorder.
    Rybakowski JK
    Harv Rev Psychiatry; 2014; 22(6):353-7. PubMed ID: 25377609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genome-wide association study identifies SESTD1 as a novel risk gene for lithium-responsive bipolar disorder.
    Song J; Bergen SE; Di Florio A; Karlsson R; Charney A; Ruderfer DM; Stahl EA; ; Chambert KD; Moran JL; Gordon-Smith K; Forty L; Green EK; Jones I; Jones L; Scolnick EM; Sklar P; Smoller JW; Lichtenstein P; Hultman C; Craddock N; Landén M; Smoller JW; Perlis RH; Lee PH; Castro VM; Hoffnagle AG; Sklar P; Stahl EA; Purcell SM; Ruderfer DM; Charney AW; Roussos P; Michele Pato CP; Medeiros H; Sobel J; Craddock N; Jones I; Forty L; Florio AD; Green E; Jones L; Gordon-Smith K; Landen M; Hultman C; Jureus A; Bergen S; McCarroll S; Moran J; Smoller JW; Chambert K; Belliveau RA
    Mol Psychiatry; 2016 Sep; 21(9):1290-7. PubMed ID: 26503763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variant GADL1 and response to lithium therapy in bipolar I disorder.
    Chen CH; Lee CS; Lee MT; Ouyang WC; Chen CC; Chong MY; Wu JY; Tan HK; Lee YC; Chuo LJ; Chiu NY; Tsang HY; Chang TJ; Lung FW; Chiu CH; Chang CH; Chen YS; Hou YM; Chen CC; Lai TJ; Tung CL; Chen CY; Lane HY; Su TP; Feng J; Lin JJ; Chang CJ; Teng PR; Liu CY; Chen CK; Liu IC; Chen JJ; Lu T; Fan CC; Wu CK; Li CF; Wang KH; Wu LS; Peng HL; Chang CP; Lu LS; Chen YT; Cheng AT;
    N Engl J Med; 2014 Jan; 370(2):119-28. PubMed ID: 24369049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical course and need for hospital admission after lithium discontinuation in patients with bipolar disorder type I or II: mirror-image study based on the LiSIE retrospective cohort.
    Öhlund L; Ott M; Bergqvist M; Oja S; Lundqvist R; Sandlund M; Renberg ES; Werneke U
    BJPsych Open; 2019 Nov; 5(6):e101. PubMed ID: 31753046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for association of an ACCN1 gene variant with response to lithium treatment in Sardinian patients with bipolar disorder.
    Squassina A; Manchia M; Borg J; Congiu D; Costa M; Georgitsi M; Chillotti C; Ardau R; Mitropoulos K; Severino G; Del Zompo M; Patrinos GP
    Pharmacogenomics; 2011 Nov; 12(11):1559-69. PubMed ID: 21961650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Systematic Review of Extracellular Matrix-Related Alterations in Parkinson's Disease.
    Chapman MA; Sorg BA
    Brain Sci; 2024 May; 14(6):. PubMed ID: 38928523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lithium-induced gene expression alterations in two peripheral cell models of bipolar disorder.
    Kittel-Schneider S; Hilscher M; Scholz CJ; Weber H; Grünewald L; Schwarz R; Chiocchetti AG; Reif A
    World J Biol Psychiatry; 2019 Jul; 20(6):462-475. PubMed ID: 29067888
    [No Abstract]   [Full Text] [Related]  

  • 37. A glutamatergic network mediates lithium response in bipolar disorder as defined by epigenome pathway analysis.
    Higgins GA; Allyn-Feuer A; Barbour E; Athey BD
    Pharmacogenomics; 2015; 16(14):1547-63. PubMed ID: 26343379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predicted Cellular and Molecular Actions of Lithium in the Treatment of Bipolar Disorder: An In Silico Study.
    Najafi H; Totonchi M; Sadeghizadeh M
    CNS Drugs; 2020 May; 34(5):521-533. PubMed ID: 32306228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lithium-associated transcriptional regulation of CRMP1 in patient-derived olfactory neurons and symptom changes in bipolar disorder.
    McLean CK; Narayan S; Lin SY; Rai N; Chung Y; Hipolito MS; Cascella NG; Nurnberger JI; Ishizuka K; Sawa AS; Nwulia EA
    Transl Psychiatry; 2018 Apr; 8(1):81. PubMed ID: 29666369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lithium ameliorates lipopolysaccharide-induced microglial activation via inhibition of toll-like receptor 4 expression by activating the PI3K/Akt/FoxO1 pathway.
    Dong H; Zhang X; Dai X; Lu S; Gui B; Jin W; Zhang S; Zhang S; Qian Y
    J Neuroinflammation; 2014 Aug; 11():140. PubMed ID: 25115727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.